Tatva Biosciences, LLC — Department of Health and Human Services SBIR Phase I: NCI

Tatva Biosciences, LLC — SBIR Phase I award from Department of Health and Human Services.

Amount
$284,341
Agency
Department of Health and Human Services · National Institutes of Health
Program / Phase
SBIR · Phase I
Topic
NCI
NAICS
Place of performance
AL
Period

Description

Despite the recognition of obvious breast cancer BC racial health disparity we have failed to reduce the BC outcome gaps in African American women Unavailability of three dimensional D tissue culture model systems that mimics the original tumor s architecture and molecular characteristics of the racially disparate breast tumors limits our advancement in this area The overall goal of this SBIR Phase I proposal is to develop a standardized protocol for the establishment of a three dimensional D tissue culture model system using tumor mass from breast cancer patients of African American and Caucasian Americanracial ethnic background We will achieve overall goal in three parts A development of D tissue culture model system from racially disparate breast tumors B phenotypic characterization of the developed D model system to confirm their stability and C functional characterization and technical validation of the developed D tissue culture models Successful completion of this highly innovative proposal will result in a novel phenotypically stable D culture model system that will be a landmark in BC racial disparity research Moreover this will provide a strong foundation for our next step in that we will pursue a Phase II for developing up to D tissue culture model system for racially disparate BC of different molecular subtypes